Rhein Biotech GmbH

RheinBiotech GmbH (Dynavax Europe) is the European affiliate of Dynavax TechnologiesCorporation (Berkeley, USA, NASDAQ: DVAX). For more than 25 years, we have beendedicated to the development and manufacturing of vaccines andbiopharmaceuticals.

DynavaxTechnologies Corporation, a clinical-stage biopharmaceutical company, developsproducts to prevent and treat infectious and inflammatory diseases and cancerbased on Toll-like Receptor (“TLR”) biology and its ability to modulate theinnate immune system. Our lead product candidate is HEPLISAV™ (also known as“HEPLISAV”), an investigational adult hepatitis B vaccine in Phase 3 clinicaldevelopment.  

RheinBiotech is headquartered in Düsseldorf, Germany. With a team of currently 75employees – some of who you can meet on our pages -we manufacture and test thehepatitis B surface antigen for our lead product candidate HEPLISAV ™(Hepatitis B vaccine.)

Is this your Organization?   Request Access


Rhein Biotech GmbH Dynavax Europe
Eichsfelder Strasse 11
Düsseldorf,   D-40595
Germany, Europe


No Contacts Created Yet

Production Lines

No Production Lines Created Yet

Copyright © Kymanox, All Rights Reserved.